Currently held
- Agent 20 — SIR Price/Volumelong4 sh @ $414.78 · stop $392.44+$41.24 unrealized
ELV
Elevance Health IncHealth Careinsider_universeLast close $425.34Sep 13, 2026
Day +1.58%
Everything we've seen
- ·Sep 14, 3:18 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 3:02 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 2:45 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 2:31 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 2:15 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 2:03 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 1:47 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 1:32 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 1:17 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 1:01 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 12:46 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 12:31 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 12:17 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 12:01 PMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 11:48 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 11:32 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 11:16 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 11:02 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 10:49 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 10:33 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 10:18 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 10:02 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 9:47 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 9:32 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ·Sep 14, 9:18 AMstreamnews
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ❖Sep 11, 9:39 PMnewsvia finnhub
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
- ❖Sep 11, 12:17 PMnewsvia finnhub
Can Centene's Medicare Advantage Strategy Unlock Better Margins?
CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.
- ❖Sep 10, 3:36 PMnewsvia finnhub
Should You Buy Elevance Health Stock For The Margin It Lost?
Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.
- ❖Sep 10, 3:05 PMnewsvia finnhub
Thursday's session: top gainers and losers in the S&P500 index
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
- ?Sep 10, 1:50 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is up 5.08% intraday, a meaningful move reflecting real institutional flow. With 115 minutes remaining there is adequate time for continuation, but this is a large move already — much of the gain may already be priced in and profit-taking risk grows as the session matures. The macro context shows elevated 5Y5Y inflation forward rates (~1.6σ above trend), which is modestly negative for rate-sensitive sectors including managed care/health insurers like ELV, creating a slight headwind. No specific catalyst headline is available for ELV itself, which is common for momentum moves — absence of news is not disqualifying. The move's magnitude (5%+) suggests a meaningful catalyst (possibly earnings revision, guidance update, or sector rotation), and large gap/surge moves in health insurance names often see institutional buying persist through the close rather than reverting same-day. However, the elevated inflation expectations could weigh on sentiment broadly. Balancing: strong momentum signal, reasonable time remaining, no reversal pattern evident, mild macro headwind — lean slight continuation.
- !Sep 10, 1:50 PMsignalseverity 0.05
Agent 7 — Day Trader — day_trade_skipped
ELV is up 5.08% intraday, a meaningful move reflecting real institutional flow. With 115 minutes remaining there is adequate time for continuation, but this is a large move already — much of the gain may already be priced in and profit-taking risk grows as the session matures. The macro context shows elevated 5Y5Y inflation forward rates (~1.6σ above trend), which is modestly negative for rate-sensitive sectors including managed care/health insurers like ELV, creating a slight headwind. No specific catalyst headline is available for ELV itself, which is common for momentum moves — absence of news is not disqualifying. The move's magnitude (5%+) suggests a meaningful catalyst (possibly earnings revision, guidance update, or sector rotation), and large gap/surge moves in health insurance names often see institutional buying persist through the close rather than reverting same-day. However, the elevated inflation expectations could weigh on sentiment broadly. Balancing: strong momentum signal, reasonable time remaining, no reversal pattern evident, mild macro headwind — lean slight continuation.
- ❖Sep 10, 1:25 PMnewsvia finnhub
UnitedHealth Reshapes Florida WellMed Operations With TPG Deal
UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.
- ❖Sep 10, 12:35 PMnewsvia finnhub
What's going on in today's session: S&P500 movers
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
- ?Sep 10, 11:55 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is up 3.84% intraday, a meaningful move representing real institutional flow. The only headline is a dividend analysis piece — benign, not a catalyst in itself, but its absence of negative news is not a disqualifier. The macro context shows 5Y5Y inflation forward (T5YIFR) running 1.6σ above trend, which modestly pressures rate-sensitive sectors; managed care / health insurers like ELV are not the most rate-sensitive names but elevated inflation expectations can weigh on broader risk appetite. With 230 minutes remaining (roughly the full afternoon session), there is ample time for the move to continue. The 3.84% move sits at the upper boundary of the 2-5% 'meaningful but not exhausted' range, suggesting some risk of profit-taking but not an overextended spike. No reversal pattern is noted. On balance, momentum bias favors continuation into the close with modest conviction — no strong tailwind beyond price action itself, but no clear fade catalyst either.
- !Sep 10, 11:55 AMsignalseverity 0.04
Agent 7 — Day Trader — day_trade_skipped
ELV is up 3.84% intraday, a meaningful move representing real institutional flow. The only headline is a dividend analysis piece — benign, not a catalyst in itself, but its absence of negative news is not a disqualifier. The macro context shows 5Y5Y inflation forward (T5YIFR) running 1.6σ above trend, which modestly pressures rate-sensitive sectors; managed care / health insurers like ELV are not the most rate-sensitive names but elevated inflation expectations can weigh on broader risk appetite. With 230 minutes remaining (roughly the full afternoon session), there is ample time for the move to continue. The 3.84% move sits at the upper boundary of the 2-5% 'meaningful but not exhausted' range, suggesting some risk of profit-taking but not an overextended spike. No reversal pattern is noted. On balance, momentum bias favors continuation into the close with modest conviction — no strong tailwind beyond price action itself, but no clear fade catalyst either.
- ❖Sep 10, 10:26 AMnewsvia finnhub
Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High
Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.
- ❖Sep 10, 10:13 AMnewsvia finnhub
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation
Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.
- ?Sep 10, 10:11 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is up 4.0% intraday, a meaningful move reflecting real institutional flow. The single headline (dividend analysis) is not a catalyst sufficient to explain a move of this magnitude, suggesting the driver is likely sector rotation, institutional positioning, or news not yet captured in headlines. With 335 minutes remaining (roughly 5.5 hours — this appears to be early in the session), there is ample time for continuation. However, offsetting factors temper conviction: (1) the macro backdrop shows elevated 5Y5Y inflation forward rates (~1.6σ above trend), which is modestly adverse for rate-sensitive sectors and managed care names like ELV that face regulatory/cost pressures; (2) a 4% move that lacks a clear fundamental catalyst risks fading as momentum traders take profits into the close; (3) managed care as a sector has faced persistent headline risk (regulatory, political) that can create sharp reversals. No reversal pattern is evident from the data provided, and the move's magnitude itself is evidence of conviction. On balance, momentum is the primary signal and continuation is the base case, but without strong confirming sector/news tailwinds, this is a modest lean rather than a high-conviction setup.
- !Sep 10, 10:11 AMsignalseverity 0.04
Agent 7 — Day Trader — day_trade_skipped
ELV is up 4.0% intraday, a meaningful move reflecting real institutional flow. The single headline (dividend analysis) is not a catalyst sufficient to explain a move of this magnitude, suggesting the driver is likely sector rotation, institutional positioning, or news not yet captured in headlines. With 335 minutes remaining (roughly 5.5 hours — this appears to be early in the session), there is ample time for continuation. However, offsetting factors temper conviction: (1) the macro backdrop shows elevated 5Y5Y inflation forward rates (~1.6σ above trend), which is modestly adverse for rate-sensitive sectors and managed care names like ELV that face regulatory/cost pressures; (2) a 4% move that lacks a clear fundamental catalyst risks fading as momentum traders take profits into the close; (3) managed care as a sector has faced persistent headline risk (regulatory, political) that can create sharp reversals. No reversal pattern is evident from the data provided, and the move's magnitude itself is evidence of conviction. On balance, momentum is the primary signal and continuation is the base case, but without strong confirming sector/news tailwinds, this is a modest lean rather than a high-conviction setup.
- ❖Sep 10, 7:04 AMnewsvia finnhub
Elevance Health Inc's Dividend Analysis
Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10. For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment. As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.
- ❖Sep 10, 2:28 AMnewsvia finnhub
Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est
Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..
- ❖Sep 10, 2:28 AMnewsvia finnhub
Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est
Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..
- ❖Sep 9, 3:30 PMnewsvia finnhub
Why Is UNH Stock Trading At A Premium With The Slowest Growth?
UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.
- ❖Sep 9, 10:40 AMnewsvia finnhub
UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation
TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.
- ?Sep 8, 12:16 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is down 1.75% today with no attributable headline catalyst, suggesting the move is driven by sector rotation or broader market pressure rather than a specific news event. The macro context shows the 5-year forward inflation rate (T5YIFR) running 1.7σ above its 24-month trend, which creates a headwind for rate-sensitive sectors broadly. Managed care / health insurers like ELV can be sensitive to rate dynamics through discount rate effects on medical cost trend assumptions and capital allocation. With 210 minutes remaining (roughly 3.5 hours), there is meaningful time for the move to extend into the close. However, the move is below the 2% threshold where momentum evidence becomes particularly compelling, and without a clear news driver or confirmed volume signal, conviction is limited. No reversal pattern is evident — the stock has simply drifted lower — which slightly favors continuation over mean reversion. The setup warrants a modest lean toward continued downside but does not qualify as a high-conviction continuation setup given the modest magnitude and absence of corroborating catalysts.
- !Sep 8, 12:16 PMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
ELV is down 1.75% today with no attributable headline catalyst, suggesting the move is driven by sector rotation or broader market pressure rather than a specific news event. The macro context shows the 5-year forward inflation rate (T5YIFR) running 1.7σ above its 24-month trend, which creates a headwind for rate-sensitive sectors broadly. Managed care / health insurers like ELV can be sensitive to rate dynamics through discount rate effects on medical cost trend assumptions and capital allocation. With 210 minutes remaining (roughly 3.5 hours), there is meaningful time for the move to extend into the close. However, the move is below the 2% threshold where momentum evidence becomes particularly compelling, and without a clear news driver or confirmed volume signal, conviction is limited. No reversal pattern is evident — the stock has simply drifted lower — which slightly favors continuation over mean reversion. The setup warrants a modest lean toward continued downside but does not qualify as a high-conviction continuation setup given the modest magnitude and absence of corroborating catalysts.
- ❖Sep 8, 10:15 AMnewsvia finnhub
2 Reasons to Watch ELV and 1 to Stay Cautious
What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
- ❖Sep 5, 5:12 PMnewsvia finnhub
Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.
- ❖Sep 4, 6:57 PMnewsvia finnhub
Dividend Champion, Contender, And Challenger Highlights: Week September 6
Explore this weekâs dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend and pay dates.
- ❖Sep 4, 1:08 PMnewsvia finnhub
Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run
After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...
- ❖Sep 4, 12:04 PMnewsvia finnhub
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.
- ?Sep 4, 10:36 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is down 1.53% today, a moderate but not dramatic move. There are no recent headlines to anchor the move to a specific catalyst, which makes it harder to assess conviction. The macro backdrop shows 5-year forward inflation expectations (T5YIFR) elevated at 1.7σ above trend — this is a mild headwind for rate-sensitive and insurance/managed care names like ELV, as higher inflation expectations can pressure medical cost outlooks and discount rates, giving the downside move some macro support. However, the move is only 1.53%, which is modest and below the 2-5% threshold where flow conviction becomes strong evidence. With 310 minutes remaining (a full session essentially, suggesting this is early-to-mid session), there is ample time for either continuation or reversal. No volume data is provided to confirm institutional selling. The absence of a news catalyst means this could be sector rotation or sympathy selling rather than a stock-specific event with legs. Balancing the mild macro headwind against the modest move magnitude and absence of strong directional evidence, I assign a borderline probability — enough to lean continuation per the system's asymmetric risk/reward structure, but not with high conviction.
- !Sep 4, 10:36 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
ELV is down 1.53% today, a moderate but not dramatic move. There are no recent headlines to anchor the move to a specific catalyst, which makes it harder to assess conviction. The macro backdrop shows 5-year forward inflation expectations (T5YIFR) elevated at 1.7σ above trend — this is a mild headwind for rate-sensitive and insurance/managed care names like ELV, as higher inflation expectations can pressure medical cost outlooks and discount rates, giving the downside move some macro support. However, the move is only 1.53%, which is modest and below the 2-5% threshold where flow conviction becomes strong evidence. With 310 minutes remaining (a full session essentially, suggesting this is early-to-mid session), there is ample time for either continuation or reversal. No volume data is provided to confirm institutional selling. The absence of a news catalyst means this could be sector rotation or sympathy selling rather than a stock-specific event with legs. Balancing the mild macro headwind against the modest move magnitude and absence of strong directional evidence, I assign a borderline probability — enough to lean continuation per the system's asymmetric risk/reward structure, but not with high conviction.
- ✓Sep 3, 8:09 PMdecisionacted
Agent 20 — SIR Price/Volume — buy
[cluster_break_up] For roughly the first 15 sessions (2026-08-07 through 2026-08-28) ELV oscillated in a tight $390–$403 band on routine volume averaging 750K–950K, forming a well-defined price cluster in 2-D PV space. The path then decisively broke out of that cluster: on 2026-09-01 volume surged to 1.1M on a +2.67% close of $403.04, on 2026-09-02 follow-through continued at 981K (+0.69% to $405.84), and today (2026-09-03) the move accelerated to a 1.2M print — a z-score of +2.31 vs the 20-day ADV of 850K — driving price to $414.78, well clear of the prior congestion zone. Three consecutive up-days on expanding, above-average volume after a sustained low-volume cluster is the textbook SIR cluster_break_up pattern: fresh demand is absorbing the float at progressively higher prices, and the multi-session confirmation (three sessions, not a single bar) satisfies the SIR path-based requirement. Risks: The elevated 5-year inflation breakeven (T5YIFR at 2.33, +1.7σ above trend) could pressure rate-sensitive Health Care names if the move re-prices further and compresses managed-care multiples; a reversal back below the cluster top (~$403) on high volume would negate the breakout and signal a failed move / distribution.
- ❖Sep 3, 4:56 PMnewsvia finnhub
Tracking Leon Cooperman's Omega Advisors Portfolio - Q2 2026 Update
- ❖Sep 3, 1:35 PMnewsvia finnhub
UnitedHealth Stock Recovered Before Its Margins Did
UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.
- ❖Sep 3, 10:45 AMnewsvia finnhub
CVS Stock Has Left Its Peers Behind. Or Has It?
The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.
- ❖Sep 2, 10:46 AMnewsvia finnhub
Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?
CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.
- ❖Sep 2, 8:57 AMnewsvia finnhub
How Is Elevance Health’s Stock Performance Compared to Other Health Providers?
Elevance Health has underperformed its industry peers over the past year, but analysts are moderately optimistic about the stock’s prospects.
- ?Sep 1, 3:16 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is up 2.49% intraday with no attributable headline, suggesting institutional flow or sector rotation rather than a news catalyst. However, with only 30 minutes remaining until the forced close, the time window is too compressed to expect meaningful additional continuation. A 2.49% move in a managed-care / health insurer like ELV is significant and likely already reflects most of the day's positioning. The macro context (2Y yields elevated at 4.34%, 2σ above trend) is modestly unfavorable for defensive/insurance names as it raises discount rates and signals risk-off positioning that could weigh on equities broadly into the close. With no fresh catalyst to drive additional buying and the session essentially in its final leg, late-day profit-taking or mean reversion is the more probable outcome. The combination of no news, compressed time, and a macro backdrop that doesn't directly favor health insurers pushes the probability below the 0.5 threshold — this is a case where the absence of a clear continuation driver, combined with the time constraint, warrants a pass.
- !Sep 1, 3:16 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
ELV is up 2.49% intraday with no attributable headline, suggesting institutional flow or sector rotation rather than a news catalyst. However, with only 30 minutes remaining until the forced close, the time window is too compressed to expect meaningful additional continuation. A 2.49% move in a managed-care / health insurer like ELV is significant and likely already reflects most of the day's positioning. The macro context (2Y yields elevated at 4.34%, 2σ above trend) is modestly unfavorable for defensive/insurance names as it raises discount rates and signals risk-off positioning that could weigh on equities broadly into the close. With no fresh catalyst to drive additional buying and the session essentially in its final leg, late-day profit-taking or mean reversion is the more probable outcome. The combination of no news, compressed time, and a macro backdrop that doesn't directly favor health insurers pushes the probability below the 0.5 threshold — this is a case where the absence of a clear continuation driver, combined with the time constraint, warrants a pass.
- ?Sep 1, 12:06 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is up 2.54% intraday with no attributable headline, suggesting institutional flow or sector rotation driving the move. With 220 minutes remaining (well over 3 hours), there is ample time for continuation toward the 3:45 PM cutoff. The macro context (elevated 2Y yields at 2.0σ above trend) is modestly negative for long-duration assets but ELV as a managed care / insurance name is relatively insensitive to short-duration rate pressure and not in the primary reactive sectors (Banks, Tech) flagged by the FRED brief. Absence of news does not disqualify the move — large intraday moves without catalysts often reflect portfolio rebalancing or sector rotation flows that persist through the session. No reversal signals are evident from the data provided; the stock is holding gains mid-session. The setup is ordinary momentum with no strong counter-thesis, warranting a modest continuation probability above the 0.5 threshold but not a high-conviction read given the lack of confirming sector narrative or volume data.
- !Sep 1, 12:06 PMsignalseverity 0.03
Agent 7 — Day Trader — day_trade_skipped
ELV is up 2.54% intraday with no attributable headline, suggesting institutional flow or sector rotation driving the move. With 220 minutes remaining (well over 3 hours), there is ample time for continuation toward the 3:45 PM cutoff. The macro context (elevated 2Y yields at 2.0σ above trend) is modestly negative for long-duration assets but ELV as a managed care / insurance name is relatively insensitive to short-duration rate pressure and not in the primary reactive sectors (Banks, Tech) flagged by the FRED brief. Absence of news does not disqualify the move — large intraday moves without catalysts often reflect portfolio rebalancing or sector rotation flows that persist through the session. No reversal signals are evident from the data provided; the stock is holding gains mid-session. The setup is ordinary momentum with no strong counter-thesis, warranting a modest continuation probability above the 0.5 threshold but not a high-conviction read given the lack of confirming sector narrative or volume data.
- ?Sep 1, 10:10 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is up 2.30% today with no attributed headline, suggesting institutional flow or sector rotation rather than a news-driven pop. With 335 minutes remaining (essentially a full trading day still ahead — this appears to be early/mid session), there is ample time for the move to extend. No macro headwind is directly applicable: the elevated 2Y yield environment (4.34, +2σ) pressures rate-sensitive sectors like Banks and Tech, but managed care/health insurance (ELV) is relatively insulated from rate duration effects and may even attract defensive rotation in a higher-rate regime. The absence of news is not a disqualifier per the framework. The move is meaningful (2.30%) and suggests real buying conviction. However, without a clear catalyst, volume confirmation, or sector news to anchor continuation, confidence is modest. No reversal pattern is evident. Assigning a slight lean toward continuation given the magnitude of the move, the defensive sector context, and ample time remaining.
- !Sep 1, 10:10 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
ELV is up 2.30% today with no attributed headline, suggesting institutional flow or sector rotation rather than a news-driven pop. With 335 minutes remaining (essentially a full trading day still ahead — this appears to be early/mid session), there is ample time for the move to extend. No macro headwind is directly applicable: the elevated 2Y yield environment (4.34, +2σ) pressures rate-sensitive sectors like Banks and Tech, but managed care/health insurance (ELV) is relatively insulated from rate duration effects and may even attract defensive rotation in a higher-rate regime. The absence of news is not a disqualifier per the framework. The move is meaningful (2.30%) and suggests real buying conviction. However, without a clear catalyst, volume confirmation, or sector news to anchor continuation, confidence is modest. No reversal pattern is evident. Assigning a slight lean toward continuation given the magnitude of the move, the defensive sector context, and ample time remaining.
- ?Aug 26, 10:10 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
ELV is up 2.24% today with no attributable headlines, suggesting institutional flow or sector rotation driving the move. With 335 minutes remaining (well over 5 hours, likely early session), there is ample time for the move to extend toward the +3% target. The macro context shows 5-year forward inflation expectations (T5YIFR) elevated at 1.6σ above trend, which is modestly negative for rate-sensitive sectors broadly, but managed care/health insurers like ELV are less directly rate-sensitive than REITs or utilities — the macro headwind here is limited. No reversal signals or fade patterns are evident from the data provided. The absence of news does not disqualify the setup; the move itself reflects real conviction. With a clean technical momentum read, bounded downside via the -1.5% stop, and sufficient time remaining, a modest continuation probability above 0.5 is warranted, though the elevated inflation expectations introduce a mild macro drag that keeps this from a high-conviction read.
- !Aug 26, 10:10 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
ELV is up 2.24% today with no attributable headlines, suggesting institutional flow or sector rotation driving the move. With 335 minutes remaining (well over 5 hours, likely early session), there is ample time for the move to extend toward the +3% target. The macro context shows 5-year forward inflation expectations (T5YIFR) elevated at 1.6σ above trend, which is modestly negative for rate-sensitive sectors broadly, but managed care/health insurers like ELV are less directly rate-sensitive than REITs or utilities — the macro headwind here is limited. No reversal signals or fade patterns are evident from the data provided. The absence of news does not disqualify the setup; the move itself reflects real conviction. With a clean technical momentum read, bounded downside via the -1.5% stop, and sufficient time remaining, a modest continuation probability above 0.5 is warranted, though the elevated inflation expectations introduce a mild macro drag that keeps this from a high-conviction read.
- ?Aug 7, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.31 cash available; close=$391.40.
- !Aug 7, 7:01 AMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $1.39 cash available; close=$391.47.
- ?Aug 7, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] ELV (Elevance Health) is down 10.3% from its 30-day high — a moderate dip within typical managed-care sector volatility. The CEO (Gail Boudreaux) made two meaningful open-market purchases on 2026-07-17 totaling ~$1M, a genuine positive signal though below the 3-insider cluster threshold. The Health Care sector (XLV) ranks 1st of 11 by 30-day relative strength and shows +2.94pts vs. SPY over 30 days, suggesting the dip is likely idiosyncratic rather than sector-driven, but the sector's strong standing reduces systemic risk. Earnings are 75 days away, removing near-term binary risk, and the macro environment (VIX at 36th percentile, normal yield curve) is not elevated-risk.
- ?Aug 6, 6:04 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $1.39 cash available; close=$391.47.
- !Aug 6, 6:04 PMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $15.74 cash available; close=$391.24.
- ?Aug 6, 6:04 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] ELV (Elevance Health) is down 10.3% from its 30-day high — a moderate dip within typical managed-care sector volatility. The CEO (Gail Boudreaux) made two meaningful open-market purchases on 2026-07-17 totaling ~$1M, a genuine positive signal though below the 3-insider cluster threshold. The Health Care sector (XLV) ranks 1st of 11 by 30-day relative strength and shows +2.94pts vs. SPY over 30 days, suggesting the dip is likely idiosyncratic rather than sector-driven, but the sector's strong standing reduces systemic risk. Earnings are 75 days away, removing near-term binary risk, and the macro environment (VIX at 36th percentile, normal yield curve) is not elevated-risk.
- ?Aug 6, 6:03 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip_no_cash
Wanted to buy but only $38.32 cash available; close=$391.47.
- !Aug 6, 6:03 PMsignal
Agent 4 — Dip Buyer (Frozen) — insufficient_capital
Wanted to buy but only $20.96 cash available; close=$391.19.
- ?Aug 6, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $15.74 cash available; close=$391.24.
- !Aug 6, 7:02 AMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $15.74 cash available; close=$391.24.
- ?Aug 6, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] ELV (Elevance Health) is down 10.3% from its 30-day high — a moderate dip within typical managed-care sector volatility. The CEO (Gail Boudreaux) made two meaningful open-market purchases on 2026-07-17 totaling ~$1M, a genuine positive signal though below the 3-insider cluster threshold. The Health Care sector (XLV) ranks 1st of 11 by 30-day relative strength and shows +2.94pts vs. SPY over 30 days, suggesting the dip is likely idiosyncratic rather than sector-driven, but the sector's strong standing reduces systemic risk. Earnings are 75 days away, removing near-term binary risk, and the macro environment (VIX at 36th percentile, normal yield curve) is not elevated-risk.
- ?Aug 5, 7:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $15.74 cash available; close=$391.24.
- !Aug 5, 7:20 PMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $12.52 cash available; close=$391.19.
- ?Aug 5, 6:04 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $12.52 cash available; close=$391.19.
- !Aug 5, 6:04 PMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Step 1: No hard vetoes fire. Earnings are 75 days away (well outside the 14-day and 15-30-day windows), the 10-Q/8-K filings show no negative metrics (empty metrics fields, no disclosed deterioration), and the drop is only 10.3% — well below the 35% extreme-drop threshold. Step 2 net signal score: +1. Positive signals: CEO Gail Boudreaux made two open-market purchases totaling ~$1M on 2026-07-17, which is a meaningful insider buy signal, though it involves only one distinct insider (below the 3-insider cluster threshold, so +1 not +2); earnings are 75 days away, providing a clean runway (+1); macro VIX at 16.5 is in the 36th percentile — benign (+1). Negative signals: the 10Y at 4.63% is above the ~4.5% structural headwind threshold, representing a mild headwind for a large managed-care insurer (-1); put/call ratio of 1.12 with slightly elevated put volume relative to calls is mildly cautious but z-scores are both negative (below-average volumes), so this is scored neutral (0). Net score: +2. With a net score of +2, no fundamental impairment, and a meaningful CEO purchase, a rebound probability of ~0.57 is calibrated just above the base rate of 55-60%, tempered modestly by the elevated 10Y yield headwind and sub-cluster insider activity.
- ?Aug 5, 6:04 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip_no_cash
Wanted to buy but only $20.96 cash available; close=$391.19.
- !Aug 5, 6:04 PMsignal
Agent 4 — Dip Buyer (Frozen) — insufficient_capital
ELV (Elevance Health) is a large, established managed care insurer with historically stable fundamentals. The 10.3% drawdown from its 30-day high is moderate, and crucially, there are no news headlines or material negative disclosures (guidance cuts, fraud, accounting issues) in the available evidence window to explain company-specific deterioration. The macro context shows inflation expectations (T5YIE) running below trend, which is generally supportive of equity valuations and could benefit healthcare insurers through lower medical cost inflation pressures. With no identifiable negative catalyst, this dip appears more consistent with sector rotation or broader market noise than fundamental impairment.
- ?Aug 5, 6:04 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] ELV (Elevance Health) is down 10.3% from its 30-day high — a moderate dip within typical managed-care sector volatility. The CEO (Gail Boudreaux) made two meaningful open-market purchases on 2026-07-17 totaling ~$1M, a genuine positive signal though below the 3-insider cluster threshold. The Health Care sector (XLV) ranks 1st of 11 by 30-day relative strength and shows +2.94pts vs. SPY over 30 days, suggesting the dip is likely idiosyncratic rather than sector-driven, but the sector's strong standing reduces systemic risk. Earnings are 75 days away, removing near-term binary risk, and the macro environment (VIX at 36th percentile, normal yield curve) is not elevated-risk.
- ?Aug 5, 7:03 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
ELV (Elevance Health) is down 12.3% from its 30-day high, a meaningful but not extreme dip for a large managed care insurer. The CEO made two open-market purchases totaling ~$1M on 2026-07-17, which is a notable positive signal of insider conviction, though it falls below the cluster threshold. However, the sector context is negative — Health Care (XLV) is underperforming SPY by 3.22 pts over 5 days with a large negative flow proxy, suggesting broad sector-wide selling pressure rather than a company-specific overreaction with an identifiable recovery catalyst. Options flow is mildly bearish (P/C ratio 1.12, both volumes below z-score thresholds), and no SEC filing metrics are available to assess fundamental deterioration or strength. With earnings 76 days out (non-factor) and macro rates moderately elevated (10Y 4.75%), the risk/reward is mixed but not clearly negative.
- !Aug 5, 7:03 AMsignalseverity 0.13
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
ELV (Elevance Health) is down 12.3% from its 30-day high, a meaningful but not extreme dip for a large managed care insurer. The CEO made two open-market purchases totaling ~$1M on 2026-07-17, which is a notable positive signal of insider conviction, though it falls below the cluster threshold. However, the sector context is negative — Health Care (XLV) is underperforming SPY by 3.22 pts over 5 days with a large negative flow proxy, suggesting broad sector-wide selling pressure rather than a company-specific overreaction with an identifiable recovery catalyst. Options flow is mildly bearish (P/C ratio 1.12, both volumes below z-score thresholds), and no SEC filing metrics are available to assess fundamental deterioration or strength. With earnings 76 days out (non-factor) and macro rates moderately elevated (10Y 4.75%), the risk/reward is mixed but not clearly negative.
- ?Aug 5, 7:03 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $58.44 cash available; close=$378.00.
- !Aug 5, 7:03 AMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $42.43 cash available; close=$378.00.
- ?Aug 4, 6:05 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $42.43 cash available; close=$378.00.
- !Aug 4, 6:05 PMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $11.23 cash available; close=$382.77.
- ?Aug 4, 6:05 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
ELV (Elevance Health) is a large, established managed care insurer with historically resilient fundamentals; no news headlines or SEC filing metrics indicate company-specific deterioration such as guidance cuts, fraud, or accounting issues. The 12.2% drawdown from the 30-day high is moderate and, absent negative catalysts, appears to reflect broader sector pressure rather than fundamental impairment. However, the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can compress managed care valuations and signal recession sensitivity, introducing meaningful headwinds for a near-term rebound.
- !Aug 4, 6:05 PMsignalseverity 0.13
Agent 4 — Dip Buyer (Frozen) — dip_skipped
ELV (Elevance Health) is a large, established managed care insurer with historically resilient fundamentals; no news headlines or SEC filing metrics indicate company-specific deterioration such as guidance cuts, fraud, or accounting issues. The 12.2% drawdown from the 30-day high is moderate and, absent negative catalysts, appears to reflect broader sector pressure rather than fundamental impairment. However, the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can compress managed care valuations and signal recession sensitivity, introducing meaningful headwinds for a near-term rebound.
- ?Aug 4, 6:04 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
ELV (Elevance Health) is down 12.3% from its 30-day high, a meaningful but not extreme dip for a large managed care insurer. The CEO made two open-market purchases totaling ~$1M on 2026-07-17, which is a notable positive signal of insider conviction, though it falls below the cluster threshold. However, the sector context is negative — Health Care (XLV) is underperforming SPY by 3.22 pts over 5 days with a large negative flow proxy, suggesting broad sector-wide selling pressure rather than a company-specific overreaction with an identifiable recovery catalyst. Options flow is mildly bearish (P/C ratio 1.12, both volumes below z-score thresholds), and no SEC filing metrics are available to assess fundamental deterioration or strength. With earnings 76 days out (non-factor) and macro rates moderately elevated (10Y 4.75%), the risk/reward is mixed but not clearly negative.
- !Aug 4, 6:04 PMsignalseverity 0.13
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
ELV (Elevance Health) is down 12.3% from its 30-day high, a meaningful but not extreme dip for a large managed care insurer. The CEO made two open-market purchases totaling ~$1M on 2026-07-17, which is a notable positive signal of insider conviction, though it falls below the cluster threshold. However, the sector context is negative — Health Care (XLV) is underperforming SPY by 3.22 pts over 5 days with a large negative flow proxy, suggesting broad sector-wide selling pressure rather than a company-specific overreaction with an identifiable recovery catalyst. Options flow is mildly bearish (P/C ratio 1.12, both volumes below z-score thresholds), and no SEC filing metrics are available to assess fundamental deterioration or strength. With earnings 76 days out (non-factor) and macro rates moderately elevated (10Y 4.75%), the risk/reward is mixed but not clearly negative.
- ?Aug 4, 7:04 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
ELV (Elevance Health) is down 12.3% from its 30-day high, a meaningful but not extreme dip for a large managed care insurer. The CEO made two open-market purchases totaling ~$1M on 2026-07-17, which is a notable positive signal of insider conviction, though it falls below the cluster threshold. However, the sector context is negative — Health Care (XLV) is underperforming SPY by 3.22 pts over 5 days with a large negative flow proxy, suggesting broad sector-wide selling pressure rather than a company-specific overreaction with an identifiable recovery catalyst. Options flow is mildly bearish (P/C ratio 1.12, both volumes below z-score thresholds), and no SEC filing metrics are available to assess fundamental deterioration or strength. With earnings 76 days out (non-factor) and macro rates moderately elevated (10Y 4.75%), the risk/reward is mixed but not clearly negative.
- !Aug 4, 7:04 AMsignalseverity 0.12
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
ELV (Elevance Health) is down 12.3% from its 30-day high, a meaningful but not extreme dip for a large managed care insurer. The CEO made two open-market purchases totaling ~$1M on 2026-07-17, which is a notable positive signal of insider conviction, though it falls below the cluster threshold. However, the sector context is negative — Health Care (XLV) is underperforming SPY by 3.22 pts over 5 days with a large negative flow proxy, suggesting broad sector-wide selling pressure rather than a company-specific overreaction with an identifiable recovery catalyst. Options flow is mildly bearish (P/C ratio 1.12, both volumes below z-score thresholds), and no SEC filing metrics are available to assess fundamental deterioration or strength. With earnings 76 days out (non-factor) and macro rates moderately elevated (10Y 4.75%), the risk/reward is mixed but not clearly negative.
- ?Aug 4, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $11.23 cash available; close=$382.77.
- !Aug 4, 7:02 AMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $10.15 cash available; close=$382.83.
- ?Aug 3, 6:04 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
ELV (Elevance Health) is a large, established managed care insurer with historically resilient fundamentals; no news headlines or SEC filing metrics indicate company-specific deterioration such as guidance cuts, fraud, or accounting issues. The 12.2% drawdown from the 30-day high is moderate and, absent negative catalysts, appears to reflect broader sector pressure rather than fundamental impairment. However, the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can compress managed care valuations and signal recession sensitivity, introducing meaningful headwinds for a near-term rebound.
- !Aug 3, 6:04 PMsignalseverity 0.12
Agent 4 — Dip Buyer (Frozen) — dip_skipped
ELV (Elevance Health) is a large, established managed care insurer with historically resilient fundamentals; no news headlines or SEC filing metrics indicate company-specific deterioration such as guidance cuts, fraud, or accounting issues. The 12.2% drawdown from the 30-day high is moderate and, absent negative catalysts, appears to reflect broader sector pressure rather than fundamental impairment. However, the macro backdrop shows a steepening yield curve (T10Y3M at 1.8σ above trend), which can compress managed care valuations and signal recession sensitivity, introducing meaningful headwinds for a near-term rebound.
- ?Aug 3, 6:03 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $54.23 cash available; close=$389.09.
- ?Aug 3, 6:03 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $10.15 cash available; close=$382.83.
- !Aug 3, 6:03 PMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $14.54 cash available; close=$375.84.
- ?Aug 3, 7:03 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $14.54 cash available; close=$375.84.
- !Aug 3, 7:03 AMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $2.50 cash available; close=$376.40.
- ?Aug 3, 7:03 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $54.23 cash available; close=$389.09.
- ?Jul 31, 6:03 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
ELV (Elevance Health) is a large, diversified managed care organization with historically strong fundamentals, and the 10.6% drop from its 30-day high lacks any clear catalyst from available evidence — no negative headlines, no visible deterioration in the sparse 10-Q/8-K filings. However, the managed care sector has faced ongoing headwinds in 2025-2026 (elevated medical cost ratios, Medicaid redetermination pressures, and regulatory scrutiny), which context suggests the drop may not be purely noise. The flat-to-slightly-steep yield curve (T10Y2Y at 0.36, 1.9σ below trend) is not particularly hostile to defensive healthcare names, but the macro environment offers limited tailwind for a swift rebound.
- !Jul 31, 6:03 PMsignalseverity 0.14
Agent 4 — Dip Buyer (Frozen) — dip_skipped
ELV (Elevance Health) is a large, diversified managed care organization with historically strong fundamentals, and the 10.6% drop from its 30-day high lacks any clear catalyst from available evidence — no negative headlines, no visible deterioration in the sparse 10-Q/8-K filings. However, the managed care sector has faced ongoing headwinds in 2025-2026 (elevated medical cost ratios, Medicaid redetermination pressures, and regulatory scrutiny), which context suggests the drop may not be purely noise. The flat-to-slightly-steep yield curve (T10Y2Y at 0.36, 1.9σ below trend) is not particularly hostile to defensive healthcare names, but the macro environment offers limited tailwind for a swift rebound.
- ?Jul 31, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.50 cash available; close=$376.40.
- !Jul 31, 7:02 AMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $10.42 cash available; close=$376.40.
- ?Jul 31, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $54.23 cash available; close=$389.09.
- ?Jul 30, 6:04 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
ELV (Elevance Health) is a large, diversified managed care organization with historically strong fundamentals, and the 10.6% drop from its 30-day high lacks any clear catalyst from available evidence — no negative headlines, no visible deterioration in the sparse 10-Q/8-K filings. However, the managed care sector has faced ongoing headwinds in 2025-2026 (elevated medical cost ratios, Medicaid redetermination pressures, and regulatory scrutiny), which context suggests the drop may not be purely noise. The flat-to-slightly-steep yield curve (T10Y2Y at 0.36, 1.9σ below trend) is not particularly hostile to defensive healthcare names, but the macro environment offers limited tailwind for a swift rebound.
- !Jul 30, 6:04 PMsignalseverity 0.14
Agent 4 — Dip Buyer (Frozen) — dip_skipped
ELV (Elevance Health) is a large, diversified managed care organization with historically strong fundamentals, and the 10.6% drop from its 30-day high lacks any clear catalyst from available evidence — no negative headlines, no visible deterioration in the sparse 10-Q/8-K filings. However, the managed care sector has faced ongoing headwinds in 2025-2026 (elevated medical cost ratios, Medicaid redetermination pressures, and regulatory scrutiny), which context suggests the drop may not be purely noise. The flat-to-slightly-steep yield curve (T10Y2Y at 0.36, 1.9σ below trend) is not particularly hostile to defensive healthcare names, but the macro environment offers limited tailwind for a swift rebound.
- ?Jul 30, 6:04 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $54.23 cash available; close=$389.09.
- ?Jul 30, 6:04 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $10.42 cash available; close=$376.40.
- !Jul 30, 6:04 PMsignal
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $38.17 cash available; close=$375.98.
- ?Jul 30, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $38.17 cash available; close=$375.98.
- ?Jul 30, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $54.23 cash available; close=$389.09.
- ?Jul 29, 6:04 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $12.83 cash available; close=$375.96.
- ?Jul 29, 6:04 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
ELV (Elevance Health) is a large, diversified managed care organization with historically strong fundamentals, and the 10.6% drop from its 30-day high lacks any clear catalyst from available evidence — no negative headlines, no visible deterioration in the sparse 10-Q/8-K filings. However, the managed care sector has faced ongoing headwinds in 2025-2026 (elevated medical cost ratios, Medicaid redetermination pressures, and regulatory scrutiny), which context suggests the drop may not be purely noise. The flat-to-slightly-steep yield curve (T10Y2Y at 0.36, 1.9σ below trend) is not particularly hostile to defensive healthcare names, but the macro environment offers limited tailwind for a swift rebound.
- ?Jul 29, 6:03 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $54.23 cash available; close=$389.09.
- ?Jul 29, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $54.23 cash available; close=$389.09.
- ?Jul 29, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $6.90 cash available; close=$385.73.
- ?Jul 28, 6:05 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $54.23 cash available; close=$389.09.
- ?Jul 28, 6:05 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $6.28 cash available; close=$385.65.
- ?Jul 28, 6:04 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
ELV (Elevance Health) is a large, diversified managed care organization with historically strong fundamentals, and the 10.6% drop from its 30-day high lacks any clear catalyst from available evidence — no negative headlines, no visible deterioration in the sparse 10-Q/8-K filings. However, the managed care sector has faced ongoing headwinds in 2025-2026 (elevated medical cost ratios, Medicaid redetermination pressures, and regulatory scrutiny), which context suggests the drop may not be purely noise. The flat-to-slightly-steep yield curve (T10Y2Y at 0.36, 1.9σ below trend) is not particularly hostile to defensive healthcare names, but the macro environment offers limited tailwind for a swift rebound.
- ?Jul 28, 7:04 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $5.71 cash available; close=$378.36.